65 -- OctreoScan-Indium In-111 Pentereotide Injection

The National Institutes of Health Clinical Center plans to negotiate a sole source contract with Mallinckrodt Medical, based in St. Louis, Missouri, for the supply of OctreoScan-Indium In-111 Pentetreotide Injection. This product, manufactured by Mallinckrodt Medical, consists of radioactive and sterile doses included in a kit with necessary components such as a 25GX5/8" needle and pressure-sensitive labels used for transferring Indium In-111 Chloride Sterile Solution to the OctreoScan Reaction Vial. Deliveries will be made weekly in small quantities of five doses each, with all shipments directed to Bethesda, Maryland. Although this notice is not a solicitation for competitive proposals, interested parties capable of providing the product may express their interest by submitting information to Mr. John Friedhoff. The government will consider all proposals received within 45 days of the notice's publication date. Additional inquiries can be directed to Mr. Friedhoff by phone at [phone hidden]. The contracting officer overseeing this effort is Ann G Argaman, who can be contacted at [email hidden] or by phone at [phone hidden].